Fund BasicsSee More
- Fund Family Cambria Funds
- Assets Under Management 35,483,000
- Shares Outstanding, K 1,850
- 60-Month Beta 1.42
- Price/Earnings ttm 18.96
- Annual Dividend & Yield 0.54
- Most Recent Dividend 0.088
- Management Fee 0.42%
|Period||Period Low||Period High||Performance|
| || |
-2.51 (-11.57%)since 03/12/21
| || |
+1.94 (+11.24%)since 01/12/21
| || |
+8.69 (+82.83%)since 04/09/20
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Given the prospect of loosening regulations and increased legalization, cannabis stocks are set to soar in 2021.
Marijuana stocks are rising on hopes of favorable regulatory environment
Cannabis stocks and ETFs jumped last week. Here's why.
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
|GW Pharmaceuticals PLC||11.56%|
|Greenlane Holdings Inc.||6.30%|
|Scotts Miracle-Gro Co.||5.96%|
|Innovative Industrial Properties Inc.||5.80%|
|CANOPY GROWTH CORP COMMON STOCK||5.10%|
|Constellation Brands Inc.||4.51%|
|Village Farms International Inc.||4.49%|
|RIV Capital Inc.||4.25%|
|3rd Resistance Point||20.37|
|2nd Resistance Point||20.11|
|1st Resistance Point||19.64|
|1st Support Level||18.91|
|2nd Support Level||18.65|
|3rd Support Level||18.18|